Rheonix Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 54

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $183M

  • Investors
  • 10

Rheonix General Information

Description

Provider of molecular testing services intended to detect pathogen and spoilage targets in food and beverage testing. The company's device offers direct tube sampling, automated amplification, open system with user-defined reagents, primers, and probes, enabling clients to have meaningful multiplexing capability at an affordable price.

Contact Information

Website
www.rheonix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30 Brown Road
  • Suite 2
  • Ithaca, NY 14850
  • United States
+1 (607)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Devices and Supplies
Biotechnology
Vertical(s)
Corporate Office
  • 30 Brown Road
  • Suite 2
  • Ithaca, NY 14850
  • United States
+1 (607)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rheonix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series B) 27-Nov-2023 $183M Completed Generating Revenue
14. Debt - PPP 05-Apr-2020 Completed Generating Revenue
13. Secondary Transaction - Private Completed Generating Revenue
12. Later Stage VC (Series B) 29-Sep-2015 Completed Generating Revenue
11. Grant 14-Apr-2015 Completed Generating Revenue
10. Debt - General 08-Jul-2014 Completed Generating Revenue
9. Grant 21-Apr-2014 Completed Generating Revenue
8. Later Stage VC (Series A) 19-Dec-2013 Completed Generating Revenue
7. Grant 06-Nov-2013 $500K $18.5M Completed Generating Revenue
6. Early Stage VC (Series A) 16-Feb-2012 $6M $18.5M Completed Startup
To view Rheonix’s complete valuation and funding history, request access »

Rheonix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Rheonix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rheonix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecular testing services intended to detect pathogen and spoilage targets in food and beverage testing. Th
Laboratory Services (Healthcare)
Ithaca, NY
54 As of 2024

Cambridge, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rheonix Competitors (27)

One of Rheonix’s 27 competitors is miniPCR, a Accelerator/Incubator Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
miniPCR Accelerator/Incubator Backed Cambridge, MA
Illumina Formerly VC-backed San Diego, CA
Cytek Formerly VC-backed Fremont, CA
Karius Venture Capital-Backed Redwood City, CA
Exagen Formerly VC-backed Vista, CA
You’re viewing 5 of 27 competitors. Get the full list »

Rheonix Patents

Rheonix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3625362-A1 Methods of analyzing genomic information Inactive 15-May-2017
AU-2018269780-A1 Methods of analyzing genomic information Inactive 15-May-2017
JP-7075138-B2 How to analyze genomic information Active 15-May-2017
AU-2022203036-A1 Methods of analyzing genomic information Inactive 15-May-2017
JP-2020519300-A Method of analyzing genomic information Active 15-May-2017 C12Q1/6816
To view Rheonix’s complete patent history, request access »

Rheonix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rheonix Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enhanced Capital Partners Asset Manager Minority
Gefinor Capital Venture Capital Minority
National Science Foundation Government Minority
NYSERDA Government Minority
National Institute of Dental and Craniofacial Research Government
You’re viewing 5 of 10 investors. Get the full list »

Rheonix Acquisitions (1)

Rheonix’s most recent deal was a Merger/Acquisition with Innovative Biotechnologies International. The deal was made on 31-Dec-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Innovative Biotechnologies International 31-Dec-2008 Merger/Acquisition Business/Productivity Software
To view Rheonix’s complete acquisitions history, request access »

Rheonix FAQs

  • When was Rheonix founded?

    Rheonix was founded in 2008.

  • Where is Rheonix headquartered?

    Rheonix is headquartered in Ithaca, NY.

  • What is the size of Rheonix?

    Rheonix has 54 total employees.

  • What industry is Rheonix in?

    Rheonix’s primary industry is Laboratory Services (Healthcare).

  • Is Rheonix a private or public company?

    Rheonix is a Private company.

  • What is the current valuation of Rheonix?

    The current valuation of Rheonix is .

  • What is Rheonix’s current revenue?

    The current revenue for Rheonix is .

  • How much funding has Rheonix raised over time?

    Rheonix has raised $243M.

  • Who are Rheonix’s investors?

    Enhanced Capital Partners, Gefinor Capital, National Science Foundation, NYSERDA, and National Institute of Dental and Craniofacial Research are 5 of 10 investors who have invested in Rheonix.

  • Who are Rheonix’s competitors?

    miniPCR, Illumina, Cytek, Karius, and Exagen are some of the 27 competitors of Rheonix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »